Clinical Features, Diagnosis, and Outcome of Encephalitis in French Guiana

Archive ouverte

Roux, Alexandre | Houcke, Stéphanie | Sanna, Alice | Mathien, Cyrille | Mayence, Claire | Gueneau, Romain | Liegeon, Geoffroy | Walter, Gaelle | Resiere, Dabor | Elenga, Narcisse | Resin, Géraldine | Djossou, Felix | Hommel, Didier | Kallel, Hatem

Edité par CCSD ; American Society of Tropical Medicine and Hygiene -

International audience. The aim of our study was to describe the clinical features, the etiologies, and the factors associated with poor outcome of encephalitis in French Guiana. Our study was retrospective, including all cases of encephalitis hospitalized in the Cayenne General Hospital, from January 2007 to July 2017. Patients were included through the 2013 encephalitis consortium criteria and the outcome was evaluated using the Glasgow outcome scale at 3 months from the diagnosis of encephalitis. We included 108 patients, giving an approximate incidence rate of four cases/100,000 inhabitants/year. The origin of the encephalitis was diagnosed in 81 cases (75%), and 72 of them (66.7%) were from an infectious origin. The most common infectious causes were Cryptococcus sp. (18.5%) independently of the immune status, Toxoplasma gondii (13.9%), and Streptococcus pneumoniae (5.5%). In the follow-up, 48 patients (46.6%) had poor outcome. Independent risk factors associated with poor outcome at 3 months were “coming from inside area of the region” ( P = 0.036, odds ratio [OR] = 4.19; CI 95% = 1.09–16.06), need for mechanical ventilation ( P = 0.002, OR = 5.92; CI 95% = 1.95–17.95), and age ≥ 65 years ( P = 0.049, OR = 3.99; CI 95% = 1.01–15.89). The most identified cause of encephalitis in French Guiana was Cryptococcus . The shape of the local epidemiology highlights the original infectious situation with some local specific pathogens.

Consulter en ligne

Suggestions

Du même auteur

Epidemiology and Prognosis of Intensive Care Unit–Acquired Bloodstream Infection

Archive ouverte | Kallel, Hatem | CCSD

International audience

Clinical Features and Management of Snakebite Envenoming in French Guiana

Archive ouverte | Resiere, Dabor | CCSD

International audience. The management of snakebite (SB) envenoming in French Guiana (FG) is based on symptomatic measures and antivenom (AV) administration (Antivipmyn Tri®; Instituto Bioclon—Mexico). Our study aim...

Severe snakebite envenomation in French Guiana: When antivenom is not available

Archive ouverte | Kallel, Hatem | CCSD

International audience

Chargement des enrichissements...